In our study, there was significant difference between SDF-1 (rs 1801157) genotype expression in AML group and control subjects, as SDF-1 dominant model (AG or AG+AA) had higher risk to develop AML (p 0.002). Here, CXCL12 is linked to acute myeloid leukemia.